Brookfield Asset Management Inc. Stryker Corp Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$271.49 - $305.09 $201,174 - $226,071	-741 Reduced 48.59%	784 $239,000
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $201,174 - $226,071	-741 Reduced 48.59%	784 $239,000
Q1 2023 Sep 25, 2023	BUY	$246.13 - $285.47 $182,382 - $211,533	741 Added 94.52%	1,525 $435,000
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $3.56 Million - $4.13 Million	-14,462 Reduced 90.46%	1,525 $435,000
Q4 2022 Feb 14, 2023	SELL	$205.51 - $253.93 $916,985 - $1.13 Million	-4,462 Reduced 21.82%	15,987 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $3.87 Million - $4.74 Million	20,449 New	20,449 $4.14 Million
Q1 2022 May 16, 2022	BUY	$245.33 - $277.77 $17.3 Million - $19.6 Million	70,527 New	70,527 $18.9 Million

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.